KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) Equity Average (2020 - 2025)

Historic Equity Average for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $586.4 million.

  • Ginkgo Bioworks Holdings' Equity Average fell 2809.78% to $586.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $586.4 million, marking a year-over-year decrease of 2809.78%. This contributed to the annual value of $906.6 million for FY2024, which is 3600.65% down from last year.
  • Ginkgo Bioworks Holdings' Equity Average amounted to $586.4 million in Q3 2025, which was down 2809.78% from $630.2 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Equity Average registered a high of $1.7 billion during Q1 2023, and its lowest value of $375.7 million during Q2 2021.
  • Its 5-year average for Equity Average is $1.1 billion, with a median of $1.0 billion in 2024.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Equity Average skyrocketed by 32476.51% in 2022 and then tumbled by 4149.01% in 2024.
  • Ginkgo Bioworks Holdings' Equity Average (Quarter) stood at $1.6 billion in 2021, then decreased by 0.16% to $1.6 billion in 2022, then dropped by 26.11% to $1.2 billion in 2023, then tumbled by 35.57% to $757.0 million in 2024, then decreased by 22.54% to $586.4 million in 2025.
  • Its Equity Average stands at $586.4 million for Q3 2025, versus $630.2 million for Q2 2025 and $681.7 million for Q1 2025.